finaceaFoam_logo

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Skin Reactions: There have been isolated reports of hypopigmentation after use of azelaic acid. Because azelaic acid has not been well studied in patients with dark complexion, monitor these patients for early signs of hypopigmentation. continue reading below ▾

For US healthcare professionals only

Do these profiles sound familiar?

Patients who would like to try a foam

Finacea® Foam patients may be new to treatment or may have tried other OTC or prescription treatments with little to no success

Patients with mild to moderate rosacea who might like to try a foam

Newly diagnosed “self-treaters”

Finacea® Foam patients may be new to treatment or may have tried other OTC or prescription treatments with little to no success

Patients who have tried OTC products but are seeking a healthcare provider to prescribe a prescription product for the first time

Newly diagnosed first-time treaters

Finacea® Foam patients may be new to treatment or may have tried other OTC or prescription treatments with little to no success

Patients who have never “self-treated” and are seeking help from their healthcare provider for the first time

Important Safety Information

Warnings and Precautions

Skin Reactions: There have been isolated reports of hypopigmentation after use of azelaic acid. Because azelaic acid has not been well studied in patients with dark complexion, monitor these patients for early signs of hypopigmentation.

Eye and Mucous Membranes Irritation: Azelaic acid has been reported to cause irritation of the eyes. Avoid contact with the eyes, mouth, and other mucous membranes. If Finacea® Foam does come in contact with the eyes, wash the eyes with large amounts of water and consult a healthcare professional if eye irritation persists.

Flammability: The propellant in Finacea® Foam is flammable. Instruct the patient to avoid fire, flame, and smoking during and immediately following application. Do not puncture and/or incinerate the containers. Do not expose containers to heat and/or store at temperatures above 120°F (49°C).

Most Common Adverse Reactions

In clinical studies, the most frequently observed adverse reactions in ≥ 0.5% of subjects treated with Finacea® Foam included local site pain (6.2%), pruritus (2.5%), dryness (0.7%), and erythema (0.7%).

For Topical Use Only

Finacea® Foam is not for oral, ophthalmic, or intravaginal use.

Avoid the use of occlusive dressings or wrappings at the application site. Avoid use of alcoholic cleansers, tinctures and astringents, abrasives, and peeling agents.

Patients should be reassessed if no improvement is observed upon completing 12 weeks of therapy.

Indication

Finacea® (azelaic acid) Foam, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.

You are encouraged to report side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).

You may also report side effects to LEO Pharma Inc. at 1-877-494-4536, option 1, or email to usdrugsafety@leo-pharma.com.

Please click here for Prescribing Information.


Terms and Conditions and Eligibility Requirements:
1. This card is good for use only with a valid prescription for Enstilar® (calcipotriene and betamethasone dipropionate) Foam 0.005%/0.064%, Picato® (ingenol mebutate) gel 0.015%, 0.05%, Finacea® (azelaic acid) Foam 15%, or Desonate® (desonide) Gel 0.05%. 2. This card is valid for up to 12 prescription fills per calendar year, up to a maximum benefit of $6000 per year for Enstilar®, or Picato®, up to a maximum benefit of $1200 per year for Finacea Foam® and up to a maximum benefit of $2400 per year for Desonate®. 3. For patients with commercial health insurance, this card may reduce out-of-pocket expenses. 4. Offer good only in the USA at participating pharmacies. 5. Original card must be presented to the pharmacist at the time the prescription is filled. Not valid if reproduced. 6. Only one card per patient. 7. The selling, purchasing, trading, or counterfeiting of this card is prohibited by the law. 8. Card is not transferable. 9. You must be 18 years of age or older to use this card. If you are under 18, a legal guardian over 18 years of age may access this program on your behalf where permitted by, and consistent with, additional restrictions imposed by law (and subject to any additional age restrictions that relate to each product). 10. This card is not health insurance. 11. You are responsible for the use of this card and for complying with reporting obligations, if any, of your insurance plan. 12. Patient is not eligible to participate in the program or use the card if enrolled in or eligible for any state or federally funded programs, including, but not limited to, Medicare (including Medicare Part D), Medicaid, Medigap, VA, DOD, TriCare, or CHIP. 13. Offer void where prohibited by law, taxed, or restricted. 14. Not valid in combination with any other offers, discounts, or programs. 15. Card has no cash value. 16. LEO Pharma Inc. reserves the right to rescind, revoke, or amend this offer without notice. 17. You understand and agree to the terms and conditions as set forth above.

Full details of the LEO Pharma® CONNECT program may be obtained by calling 1-877-678-7494 between 8:30 AM and 8:30 PM (Eastern), Monday through Friday.

Close